1.Combined use of PI3K and MEK inhibitors synergistically inhibits lung cancer with EGFR and KRAS mutations
Jiang, ZB, Huang, J,
More...
Jiang, ZB, Huang, J, Xie, C, Li, X, Liu, L, He, J, Pan, H, Huang, L, Fan, XX, Ya, XJ, Xie, Y, Li, N, Liu, L, He, JX, Leung, ELH
Less
ONCOLOGY REPORTS[1021-335X],
Published 2016,
Volume 36,
Issue 1,
Pages 365-375
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 12
2023影響因子:
3.8
发表年影響因子:
2.662
